Cargando...
Emerging Immunopharmacological Targets in Multiple Sclerosis
Inflammatory demyelination of the central nervous system (CNS) is the hallmark of multiple sclerosis (MS), a chronic debilitating disease that affects more than 2.5 million individuals worldwide. It has been widely accepted, although not proven, that the major pathogenic mechanism of MS involves mye...
Guardado en:
| Publicado en: | J Neurol Sci |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215047/ https://ncbi.nlm.nih.gov/pubmed/26440421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2015.09.346 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|